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E-mail address: Inouye@umdnj.edu (M. Inouye).MazF is anmRNA interferase which cleaves mRNAs at a speciﬁc sequence. Here, we show that in con-
trast to MazF-ec from Escherichia coli, which speciﬁcally cleaves ACA sequences,MazF-bs from Bacil-
lus subtilis is an mRNA interferase that speciﬁcally cleaves a ﬁve-base sequence, UACAU. MazF
homologues widely prevailing in Gram-positive bacteria were found to be highly homologous to
MazF-bs, suggesting that they may also have similar cleavage speciﬁcity. This cleavage site is over-
represented in the B. subtilis genes associated with biosynthesis of secondary metabolites, suggest-
ing that MazF-bs may be involved in the regulation of the production of secondary metabolites.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MazF is an mRNA interferase originally discovered in Escherichia
coli as a toxin that speciﬁcally cleaves intracellular mRNAs at ACA
sequences [1]. In normally growing cells, MazF-ec (MazF from
E. coli) forms a stable complex with its cognate antitoxin, MazE-
ec, however, under stress conditions, unstable MazE-ec is preferen-
tially degraded to release free MazF-ec in the cells, which then
cleaves cellular mRNAs to inhibit protein synthesis, leading to
growth arrest [2]. Since the discovery of MazF-ec, a number of
MazF homologues and other mRNA interferases with different
mRNA cleavage speciﬁcities have been found [3]. Mycobacterium
tuberculosis has at least seven MazF homologues (MazF-mt1 to -
mt7), four of which (MazF-mt1, -mt3, -mt4, and -mt6) cause cell
growth arrest when induced in E. coli. MazF-mt1 and MazF-mt6
cleave mRNAs at UAC triplet sequences and at U-rich regions,
respectively [4]. Furthermore, MazF-mt3 cleaves RNAs at UU^CCU
or CU^CCU, while MazF-mt7 cleaves at U^CGCU (^ indicates the
cleavage site) [5]. These pentad sequences are signiﬁcantly under-
represented in several genes, including members of the PE and PPE
families, large families of proteins that play a role in tuberculosis
immunity and pathogenesis. It has also been demonstrated that a
MazF homologue from Myxococcus xanthus (MazF-mx) is essential
for the programmed cell death of this developmental bacteriumchemical Societies. Published by Eduring the fruiting body formation [6]. MazF-ec has been shown
to be toxic when induced in mammalian cells, causing Bak-
dependent programmed cell death [7]. Recently, we reported that
CD4+ cells carrying the E. coli mazF gene under the Tar promoter
from HIV-1 acquires resistance to HIV-1 infection [8].
Staphylococcus aureus contains one MazF homologue, MazF-sa,
which has been shown to cleave mRNA at VUUV0 (V and V0 are A,
C, or G) [9,10]. However, MazF-sa was found to have more strin-
gent cleavage speciﬁcity and cleaves mRNAs at UACAU sequences.
The 3.5 kb MS2 phage RNA was used as a substrate. As MazF and its
homologues cleave single-stranded RNAs and the MS2 phage RNA
contains few secondary structures, the reaction was carried out in
the presence of CspA, an RNA chaperone, which prevents the for-
mation of secondary structures in RNA [11]. Bacillus subtilis also
contains a MazF homologue, MazF-bs (EndoA) [12]. The crystal
structure of MazF-bs has been determined [13], which is very sim-
ilar to those of E. coli MazF-ec [14] and Kid [15] proteins. As seen
from the crystal structure, MazF-bs forms a homo-dimer with each
monomer containing two a-helices and seven b-strands.
The consensus cleavage sequence for MazF-bs was determined
previously to be UAC [12,16] with the use of a 375-base RNA con-
taining the thrS leader region [16]. The identity and homology be-
tween MazF-bs and MazF-sa are 62.8% and 79.3%, respectively,
while those between MazF-bs and MazF-ec are only 18.3% and
40.5%, respectively. Notably, MazF-sa speciﬁcally cleaves RNAs at
a pentad sequence, UACAU, and its induction in E. coli only slows
the growth as opposed to the complete inhibition of cell growthlsevier B.V. All rights reserved.
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that a 5-base cutter such as MazF-mt3 could be expressed in E. coli
without co-expression of its cognate antitoxin since a 5-base cutter
is much less toxic than a 3-base cutter [5]. Therefore, here, we
reexamine the cleavage site speciﬁcity of MazF-bs and how the
MazF-bs cleavage site is represented in some speciﬁc groups of
genes in B. subtilis.Fig. 1. Sequence alignments of MazF-bs with other MazF homologues in Gram-positiv
interferases are known (B). (bs: Bacillus subtilis, ba: Bacillus anthracis, bc: Bacillus cereus, lm
Thermoanaerobacter tengcongensis, cd: Clostridium difﬁcile, cp: Clostridium perfringens, cb: C
coli, mt:Mycobacterium tuberculosis, and mx:Myxococcus xanthus). White and black boxes
respectively.2. Materials and methods
2.1. Bacterial strains and plasmids
E. coli BL21 (DE3) was used. The mazF-bs (endoA) and mazE-bs
(endoAI) genes in the mazEF operon were separately ampliﬁed by
PCR using the B. subtilis 168 genomic DNA as a template and clonede bacteria (A) and in bacteria which RNA cleavage speciﬁcities of mazF type RNA
: Listeria monocytogenes, da: Dethiobacter alkaliphilus, ho: Halothermothrix orenii, tt:
lostridium botulinum, c: Carnobacterium sp., sa: Staphylococcus aureus, ec: Escherichia
indicate b-sheets and a-helices on the basis of the secondary structures of MazF-bs,
2528 J.-H. Park et al. / FEBS Letters 585 (2011) 2526–2532into pColdIII (TaKaRa Bio) and pET21c (Novagen), respectively with
primers (MazF-bs forward: TATACATATGATTGTGAAACGC and
MazF-bs Reverse (His6: TATAGAATTCTTAATGATGATGATGATGAT
GAAAATCAATGAGTGC). Subsequently, the mazF-bs gene was
cloned into pBAD33.
2.2. Protein puriﬁcation
To purify C-terminal His6-tagged MazF-bs, pCold-mazF-bs was
introduced into E. coli BL21(DE3). The expression of MazF-bs was
induced by treatment with 0.5 mM isopropyl-b-D-1-thiogalacto-
side (IPTG) for 3 h at 37 C. MazF-bs was puriﬁed with Ni-NTA aga-
rose (Qiagen) following the manufacturer’s protocol.
2.3. Primer extension
For primer extension analysis of mRNA cleavage sites in vitro,
0.8 lg phage MS2 RNA (Roche) was incubated with and without
puriﬁed MazF-bs protein in the presence and absence of CspA pro-
tein (32 lg) at 37 C for 5 min in a reaction mixture (10 ll) con-
taining 10 mM Tris–HCl (pH 8.0) and 0.5 ll RNase inhibitor
(Roche). Primer extension was carried out at 47 C for 1 h as de-
scribed previously [17]. The reactions were stopped by sequence
loading buffer (95% formamide, 20 mM EDTA, 0.05% bromophenol+                              -                           +             0.0
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Fig. 2. Induction of MazF-bs and MazE-bs in E. coli. E. coli BL21(DE3) was transformed usi
cells were then grown on M9 plates containing 0.2% glycerol and casamino acids with 0.
plates were incubated at 37 C for 18 h. (D) Growth curves of E. coli BL21 (DE3) cells harb
the presence (closed circles) or absence (open circles) of 0.1 mM IPTG. After 2 h, the cel
circles) or absence (open circles) of 0.1 mM IPTG.blue, and 0.05% xylene cyanol EF). The samples were incubated at
90 C for 5 min prior to electrophoresis on a 6% polyacrylamide gel
containing 8 M urea.
2.4. Analysis of MazF-bs cleavage sites in B. subtilis genome
The genomic sequence of B. subtilis 168 was retrieved from NCBI
RefSeq (accession no. NC_000964) and all coding sequences (CDS)
were extracted from the record. The nucleotide composition of
each CDS was calculated by using Perl script.
3. Results
3.1. MazF-bs has high homology to MazF homologues in Gram-positive
bacteria
Using BLAST search, we found that MazF-bs has signiﬁcant
identity (62.8–94%) and similarity (79.3–96.6%) to MazF homo-
logues from various Gram-positive bacteria (Fig 1A). However,
MazF-bs has low identity (19.2–37.3%) and similarity (38.3–
55.9%) to MazF homologues from Gram-negative bacteria
(Fig. 1B). Although Clostridium botulinum and C. difﬁcile are located
far from B. subtilis in the 16S rRNA phylogenetic tree (Supplemen-
tary Fig. 1A), these MazF homologues show high identity (66.4%5 mM IPTG  
1
2
3
1: pET21c
2: pET21c-MazEec pBAD33-MazFbs
3: pET21c-MazEbs pBAD33-MazFbs
pBAD33
 Vector for 
antitoxin expression toxin expression
% Arabinose
 Vector for 
ng pBAD33-mazF-bs together with pET21c-mazE-bs or pET21c-mazE-ec. Transformed
05 mM IPTG (A), 0.1% arabinose (B), and 0.05 mM IPTG plus 0.1% arabinose (C). The
oring pColdIII-mazF-bs. The cells were grown in M9-glucose liquid medium at 37C in
l culture was diluted 10-fold by M9-glucose liquid medium in the presence (closed
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tively) to MazF-bs (Fig. 1A) and are located close to MazF-bs in
the protein phylogenetic tree (Supplementary Fig. 1B).
To examine if MazF homologues exist in other Gram-positive
bacteria, we used BLASTCLUST (BLAST score-based single-linkageTable 1
Cleavage sites of MazF-bs in MS2 RNA.
Cleavage site
With U^ACAU
UGACU U^ACAU CGAAG
GGUUU U^ACAU AAACG
GCUCC U^ACAU GUCAG
UUUCU U^ACAU GACAA
CGUUU U^ACAU CAAGA
GUCGC U^ACAU AGCGU
With sequence differing from U^ACAU by 1 base
GAUGG U^CCAU ACCUU
GUGGU U^CCAU ACUGG
CGUCG U^ACCU UAGCU
UUGCU U^ACUU AAGGG
ACUAC U^ACGU AGUCA
GUUCG U^ACUU AAAUA
A
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Fig. 3. Primer extension analysis of MazF-bs cleavage sites in MS2 RNA. CspA was added
arrows on the RNA sequences were determined using the RNA ladder shown on the leftclustering), which is part of the NCBI BLAST package. This program
clusters proteins based on pairwise matches found by using the
BLAST algorithm. To date, predicted TA systems are collected in
the TADB database (total of 20816 protein sequences) [18] and
we used this database for running BLASTCLUST. Minimum length
coverage and similarity threshold in BLASTCLUST used were 0.8%
and 60%, respectively. A cluster of proteins including MazF-bs
had a total of 102 toxins from 99 strains of which two strains were
Gram-negative strains and all other 97 strains were Gram-positive
bacteria (data not shown). This result showed that MazF-bs homo-
logues are mainly located in Gram-positive bacteria and MazF-bs
homologues in Gram-positive bacteria have wide-ranging distribu-
tion in Gram-positive bacteria.
3.2. MazF-bs is toxic in E. coli and is neutralized by MazE-bs
ThemazF-bs gene was cloned in the pBAD33 plasmid which was
designated as pBAD-mazF-bs. ThemazE-ec andmazE-bs genes were
cloned in pET21c (Novagen) and designated as pET21c-mazE-bs or
pET21c-mazE-ec, respectively, as described in Materials and Meth-
ods. E. coli BL21 (DE3) cells were co-transformed with these plas-
mids to express the toxin (MazF-bs), antitoxin (MazE-bs and
MazE-ec), or both of them together (MazF-bs with MazE-bs or                       
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in all reactions (A–F) except for lanes 6 and 8 in A and B. Cleavage sites indicated by
. Consensus sequence, UACAU, was underlined.
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formed colonies in the presence of 0.05 mM IPTG, without 0.1%
arabinose wherein only MazE-bs was induced (Fig. 2A). However,
when only MazF-bs was induced in the presence of 0.1% arabinose
(Fig. 2B) or when MazF-bs was induced with MazE-ec, (Fig. 2C), no
colonies were formed. The data indicated that MazE-ec cannot
neutralize MazF-bs toxicity in E. coli although MazF-bs toxicity
can be neutralized by MazE-bs (Fig. 2C).
We also examined the effect of MazF-bs induction in a liquid
culture on cell growth. MazF-bs expression was induced with
0.1 mM IPTG. As shown in Fig. 2D, growth inhibition was observed
only after 2 h induction but cell growth was not completely inhib-
ited, which is in a sharp contrast to the induction of MazF-ec,
which inhibits cell growth within 30 min after induction [1]. There
was a difference in the effects of toxicity exerted by MazF-bs and
MazF–ec on plates. Cells expressing MazF-bs were able to form col-
onies in the presence of 0.05% arabinose, while cells expressing
MazF-ec were not able to form colonies in the presence of 0.05%
arabinose, indicating that MazF-bs is less toxic than MazF-ec upon
heterologous expression in E. coli (data not shown).
3.3. MazF-bs speciﬁcally cleaves RNA at UACAU
MazF-bs was puriﬁed to determine its cleavage speciﬁcity. For
this purpose, 3.5-kb phage MS2 RNA was used as a substrate. After
incubating MS2 RNA with and without puriﬁed MazF-bs, the prod-
ucts were analyzed by primer extension as described previously
[17]. Through these experiments, a total of twelve cleavage sites
were identiﬁed as listed in Table 1. Six of them consisted of a con-
sensus sequence, UACAU (Fig. 3). The remaining six cleavage sites
contained a base substitution either at the second base or the
fourth base in the consensus sequence. Among the sites with the        L     -    +     L   -     +   L    -     +   L    -      +     : MazF-bs     
RNA1 RNA2 RNA3 RNA4
15 bases
RNA1: 5’-AGAUCU^ACAUAUGAA-3’
RNA2: 5’-AGAUGU^ACAUAUGAA-3’
RNA3: 5’-AGAUAU^ACAUAUGAA-3’
RNA4: 5’-AGAUCU^ACAUUUGAA-3’
Fig. 4. In vitro cleavage of the four different oligoRNAs with MazF-bs. Each
oligoRNA was incubated without or with MazF-bs for 5 min. Black arrow indicates
the bands which show the full sizes of oligoRNA (15 bases). Each RNA ladder was
prepared by the treatment of sodium hydroxide in all kinds of RNA oligos. L is RNA
ladder.single base substitutions, two UCCAU and one UACUU showed
band intensity stronger than the other three sequences but not
as strong as at the consensus sequences. Notably, VACAU or UACAV
(where V = G, A, and C) were not cleaved even in the presence of
CspA (Supplementary Fig. 2). These results indicate that MazF-bs
cleaves RNA with a high speciﬁcity for UACAU.
MS2 RNA was unable to cover all four nucleotides at positions
1 and +5 in the consensus sequence (ﬁrst U residues is designated
as +1). All six UACAU sequences found in MS2 RNA have only U or C
at position 1 and C, A, or G at position +5. Therefore, four oligoR-
NAs were synthesized to cover the entire sequence of MS2 RNA.
RNA1 (50-AGAUCUACAUAUGAA-30 [control]), RNA2 (50-AGAUGUA-
CAUAUGAA-30), RNA3 (50-AGAUAUACAUAUGAA-30), RNA4 (50-
AGAUCUACAUUUGAA-30) (bases at position 1 and +5 are under-
lined), RNA2 and RNA3 have G and A in position 1 and RNA4
has U residue at position +5. However, the replacement of residues
at position 1 or +5 did not affect the cleavage activity of MazF-bs
in comparison with the control RNA (RNA1) and MS2 RNA experi-
ments (Fig. 4). These results indicate that MazF-bs cleaves RNA at a
ﬁve-base sequence, UACAU.
3.4. Signiﬁcant abundance of the pentad sequence in the genes
involved in secondary metabolite biosynthesis, transport and
catabolism in B. subtilis
We analyzed the number of the pentad sequence in every ORF
on the B. subtilis genome (4,176 ORFs) (accession no. NC_000964)
with the use of a Perl script in descending order. As shown in Table
2, ten of the top twenty genes containing the pentad sequence are
involved in secondary metabolite biosynthesis, transport and
catabolism according to the COG database [19]. In the S. aureus
genome, the genes which contain signiﬁcantly abundant MazF-sa
cleavage sites have been identiﬁed to be related to pathogenic fac-
tors [11], however, none of the top ten UACAU-rich genes in S. aur-
eus were found to exist in the B. subtilis genome, because B. subtilis
is not pathogen.4. Discussion
We showed that MazF from B. subtilis has high homology with
MazF homologues widely found in Gram-positive bacteria, includ-
ing pathogenic Gram-positive bacteria such as B. cereus causing
food poisonings [20], B. anthracis causing anthrax, a virulent and
highly contagious disease and S. aureus causing invasive infections
such as pneumonia, osteomyelitis, and endocarditis [21]. MazF-bs
likely plays a similar role in cell physiology as other MazF homo-
logues in other Gram-positive bacteria.
Using the BLASTCLUST program, it was found that MazF-bs is
widely prevailing Gram-positive bacteria; a total of 102 MazF
homologues from 99 strains (61 species), of which 97 strains are
Gram-positive bacteria. TA systems are proposed to have invaded
the bacterial genomes using horizontal gene transfer [22], and
the 99 strains mentioned above are erratically distributed in the
phylogenetic tree based on 16S rRNA. Nevertheless, MazF-bs
homologues appear to be preferentially located in Gram-positive
bacteria. For example, S. aureus and Halothermothrix orenii are lo-
cated far from B. subtilis in the phylogenetic tree, but both MazF-
sa and MazF–ho have signiﬁcantly high homology with MazF-bs
(Supplementary Fig. 1B). Interestingly, the protein multiple align-
ment of MazF homologues in the 99 strains described above shows
high variations in their C-terminal regions. It remains to be eluci-
dated if the C-terminal regions have a speciﬁc function for each
strain during evolution. The BLASTCLUST analysis showed that
there are a total of 27 MazF-ec homologues, which are only from
6 different species. Furthermore, out of the 27 MazF-ec homo-
Table 2
Top 20 genes including the high number of UACAU that is the consensus sequence of MazF-bs in the B. subtilis genome. COG (Clusters of Orthologous Groups of proteins) is a
database delineated by comparing protein sequences encoded in complete genomes, representing major phylogenetic lineages [19].
Rank #UACAU Length (bp) PID Gene COG Product
1 17 16467 255767399 pksN COG3321Q Polyketide synthase of type I
2 16 12789 255767398 pksM COG3321Q Polyketide synthase
3 15 15132 255767396 pksJ COG3321Q Polyketide synthase of type I
4 12 10752 255767106 srfAB COG1020Q Surfactin synthetase
5 12 10764 255767105 srfAA COG1020Q Surfactin synthetase
6 12 13617 255767397 pksL COG3321Q Polyketide synthase of type I
7 11 3255 50812254 nrdEB COG0209F Phage SPbeta phage ribonucleoside-diphosphate reductase, alpha subunit
8 11 7668 16078893 ppsC COG1020Q Plipastatin synthetase
9 11 10812 255767428 ppsD COG1020Q Plipastatin synthetase
10 9 2520 16079163 yonO – Conserved hypothetical protein; phage SPbeta
11 9 7686 255767429 ppsA COG1020Q Plipastatin synthetase
12 8 1218 255767470 yonJ – Conserved hypothetical protein; phage SPbeta
13 7 3606 16078957 yobI – Putative NTPase with transmembrane helices
14 7 7005 255767831 wapA COG3209 M Cell wall-associated protein precursor
15 7 7137 255767732 dhbF COG1020Q Siderophore 2,3-dihydroxybenzoate glycine-threonine trimeric ester bacillibactin synthetase
16 6 588 16079041 yotM COG3331R Hypothetical protein; SPbeta phage
17 6 1038 16079717 yrdP COG2072P Putative oxidoreductase
18 6 1947 255767270 manR COG3711 K Transcriptional antiterminator
19 6 1995 16077106 metS COG0143 J Methionyl-tRNA synthetase
20 6 2874 16080569 uvrA COG0178L Excinuclease ABC subunit A
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that MazF-bs homologues are wildly prevailing in various Gram-
positive bacteria, while the distribution of MazF-ec homologues
is more limited to a very few bacterial species.
Although there is a very high structural similarity between
MazF-bs and MazF–ec [12], MazE-ec could not neutralize MazF-
bs toxicity, suggesting that each antitoxin has been co-evolved
with its cognate toxin. MazE antitoxins of MazF homologues
shown in Fig. 1A have high homology to MazE-bs but not to
MazE-ec although MazEs in Gram-negative bacteria are not pre-
served (data not shown). It was conﬁrmed that MazF-bs is neu-
tralized by MazE-bs by using two different induction systems in
E. coli as reported before using Pspac-ydcDE to induce both pro-
teins [12].
As shown in Fig. 2D, MazF-bs expression did not severely inhibit
cell growth. Since MazF-ec cleaving RNAs at ACA sequences com-
pletely inhibits cell growth 30 min after induction, our data well
correspond to the result that MazF-bs cleaves RNAs at a speciﬁc
ﬁve-base sequence rather than a three-base sequence. As a result,
MazF-bs alone was well expressed in E. coli without its cognate
antitoxin, MazE-bs. Statistically a unique pentad sequence can be
found only once in every 1,024-base sequence, provided that the
RNA contains equal numbers of bases and has random sequence.
Therefore, MS2 RNA consisting of 3,569 nucleotides is expected
to contain at least three pentad sequences and actually six consen-
sus cleavage sites, UACAU were found in the RNA. From the analy-
sis of minor cleavage sites, we concluded that MazF-bs RNA
cleavage sites are neither XACAU nor UACAX (where X=G, A, and
C). MazF-sa and MazF-bs were found to share the same pentad
cleavage speciﬁcity, suggesting that other MazF homologues from
Gram-positive bacteria listed in Fig. 1 may also have the same
cleavage speciﬁcity.
B. subtilis produces more than twenty four different antibiotics
[23]. Among them, nine genes involved in the synthesis of three
antibiotics are major targets for MazF-bs (Table 2). Surfactin is
one of the 24 antibiotics produced by B. subtilis [24] and plipastatin
is a lipopeptide antifungal antibiotic [25]. The srfAB and srfAA genes
encode surfactin synthetases, which are essential for bioﬁlm for-
mation [26]. It was also shown that surfactin can act as a signal
molecule to induce bioﬁlm formation similar to a quorum sensing
inducer [27]. These results suggest that MazF-bs may be involved
in regulation of bioﬁlm formation. Although the biological function
of polyketide and plipastatin antibiotics is not well understood inB. subtilis, polyketide has been shown to play a role in self-defense,
aggression and communication [28]. In S. aureus, the mRNA for
SraP contains an unusually large number of a pentad sequence, UA-
CAU (a total of 43), the speciﬁc cleavage site for MazF-sa [11]. SraP
is homologous to GspB of S. gordonii which is a glycol protein
which enhances cell communication between the pathogen and
human platelets [29]. It is interesting to further investigate if MazF
homologues in Gram-positive bacteria may play an important role
in cell-cell communication and bioﬁlm formation. The actual roles
and functions of MazF-bs in B. subtilis remain to be elucidated.
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